184 related articles for article (PubMed ID: 12594127)
21. Effect of infliximab on threatening panuveitis in Behçet's disease.
Muñoz-Fernández S; Hidalgo V; Fernández-Melón J; Schlincker A; Martín-Mola E
Lancet; 2001 Nov; 358(9293):1644. PubMed ID: 11716917
[No Abstract] [Full Text] [Related]
22. The efficacy of a single dose of infliximab in the treatment of Behçet's disease uveitis.
Arayssi T; Hamra R; Homeidan F; Uthman I; Awwad ST; Mroue K; Mansour W; Bashshur ZF
Clin Exp Rheumatol; 2005; 23(3):427. PubMed ID: 15971438
[No Abstract] [Full Text] [Related]
23. Successful treatment of leg ulcers in Behçet's disease using adalimumab plus methotrexate after the failure of infliximab.
Atzeni F; Leccese P; D'Angelo S; Sarzi-Puttini P; Olivieri I
Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S94. PubMed ID: 20868581
[No Abstract] [Full Text] [Related]
24. Successful treatment of recalcitrant genital ulcers of Behçet's disease with adalimumab after failure of infliximab and etanercept.
Olivieri I; D' Angelo S; Padula A; Leccese P; Mennillo GA
Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S112. PubMed ID: 19796550
[No Abstract] [Full Text] [Related]
25. Refractory pseudoseptic arthritis in Behçet's disease successfully treated with infliximab: a case report and literature review.
Sifuentes Giraldo WA; Guillén Astete CA; Murillo Romero C; Amil Casas I; Rodríguez García AM; Bachiller Corral FJ
Mod Rheumatol; 2014 Jan; 24(1):199-205. PubMed ID: 24261779
[TBL] [Abstract][Full Text] [Related]
26. Infliximab in the treatment of hepatic vein thrombosis (Budd-Chiari syndrome) in three patients with Behcet's syndrome.
Seyahi E; Hamuryudan V; Hatemi G; Melikoglu M; Celik S; Fresko I; Yurdakul S; Yazici H
Rheumatology (Oxford); 2007 Jul; 46(7):1213-4. PubMed ID: 17478465
[No Abstract] [Full Text] [Related]
27. Infliximab for the treatment of resistant oral ulcers in Behçet's disease: a case report and review of the literature.
Almoznino G; Ben-Chetrit E
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S99-102. PubMed ID: 17949561
[TBL] [Abstract][Full Text] [Related]
28. Blind insight: eyeing anti-tumor necrosis factor treatment in uveitis associated with Behçet's disease.
Rosenbaum JT
J Rheumatol; 2004 Jul; 31(7):1241-3. PubMed ID: 15229938
[No Abstract] [Full Text] [Related]
29. [Treatment of severe Behçet's disease with anti-TNF-alpha: infliximab. A case report].
Andreu M; Ramanoelina J; Fajnkuchen F; Mouthon L; Cohen P; Laroche L; Guillevin L
Ann Med Interne (Paris); 2002 Oct; 153(6):414-5. PubMed ID: 12486393
[No Abstract] [Full Text] [Related]
30. [Infliximab treatment for Behçet's disease--beginning of the biological drug era].
Namba K
Nippon Ganka Gakkai Zasshi; 2010 Feb; 114(2):85-6. PubMed ID: 20187504
[No Abstract] [Full Text] [Related]
31. Treatment of intestinal Behçet's syndrome with chimeric tumour necrosis factor alpha antibody.
Travis SP; Czajkowski M; McGovern DP; Watson RG; Bell AL
Gut; 2001 Nov; 49(5):725-8. PubMed ID: 11600479
[TBL] [Abstract][Full Text] [Related]
32. Interferon-a (IFN-a) application versus tumor necrosis factor-a antagonism for ocular Behçet's disease: focusing more on IFN.
Kotter I; Deuter C; Stubiger N; Zierhut M
J Rheumatol; 2005 Aug; 32(8):1633; author reply 1634. PubMed ID: 16078350
[No Abstract] [Full Text] [Related]
33. Neuro-Behçet's disease, its mimickers and anti-TNF therapy: a case-based review.
Neves FS; Ferreira RM; Pereira IA; Zimmermann AF; Lin K
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):133-40. PubMed ID: 23739034
[TBL] [Abstract][Full Text] [Related]
34. Effect of infliximab in progressive neuro-Behçet's syndrome.
Kikuchi H; Aramaki K; Hirohata S
J Neurol Sci; 2008 Sep; 272(1-2):99-105. PubMed ID: 18550081
[TBL] [Abstract][Full Text] [Related]
35. Effects of anti-TNF-alpha antibody infliximab in refractory entero-Behcet's disease.
Iwata S; Saito K; Yamaoka K; Tsujimura S; Nawata M; Suzuki K; Tanaka Y
Rheumatology (Oxford); 2009 Aug; 48(8):1012-3. PubMed ID: 19465589
[No Abstract] [Full Text] [Related]
36. Treatment of retinal vasculitis in Behçet's disease with rituximab.
Sadreddini S; Noshad H; Molaeefard M; Noshad R
Mod Rheumatol; 2008; 18(3):306-8. PubMed ID: 18438602
[TBL] [Abstract][Full Text] [Related]
37. Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations.
Sfikakis PP; Markomichelakis N; Alpsoy E; Assaad-Khalil S; Bodaghi B; Gul A; Ohno S; Pipitone N; Schirmer M; Stanford M; Wechsler B; Zouboulis C; Kaklamanis P; Yazici H
Rheumatology (Oxford); 2007 May; 46(5):736-41. PubMed ID: 17403712
[No Abstract] [Full Text] [Related]
38. Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report.
Gulli S; Arrigo C; Bocchino L; Morgante L; Sangari D; Castagna I; Bagnato GF
BMC Musculoskelet Disord; 2003 Aug; 4():19. PubMed ID: 12946278
[TBL] [Abstract][Full Text] [Related]
39. Treatment of recalcitrant orogenital ulceration of Behçet's syndrome with infliximab.
Robertson LP; Hickling P
Rheumatology (Oxford); 2001 Apr; 40(4):473-4. PubMed ID: 11312390
[No Abstract] [Full Text] [Related]
40. Adalimumab: a new modality for Behçet's disease?
van Laar JA; Missotten T; van Daele PL; Jamnitski A; Baarsma GS; van Hagen PM
Ann Rheum Dis; 2007 Apr; 66(4):565-6. PubMed ID: 17124248
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
